Skip to main content
Annie Im, MD, Oncology, Pittsburgh, PA, Shadyside Campus

AnniePearlImMD

Oncology Pittsburgh, PA

Hematologic Oncology

Physician

Dr. Im is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Im's full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2010 - 2013
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2006 - 2010
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2006

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2006 - 2024
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The eGVHD App Has the Potential to Improve the Accuracy of Graft Versus Host Disease Assessment: A Multicenter Randomized Controlled Trial  
    Annie Im, Steven Z Pavletic, Haematologica

Abstracts/Posters

  • Accrual Barriers and Detection of Early Toxicity Signal in Older Less-Fit Patients Treated with Azacitidine and Nivolumab for Newly Diagnosed Acute Myeloid Leukemia (A...
    Annie Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy
    Annie Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic Gvhd
    Annie Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309) 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Training Program DirectorsÍ Workshop 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Training Program DirectorsÍ Workshop 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • Best Outcomes After Stopping TKIs for CML Are in Patients with at Least Five Years of Deep Molecular Remission
    Best Outcomes After Stopping TKIs for CML Are in Patients with at Least Five Years of Deep Molecular RemissionJune 7th, 2022
  • Without Older Subjects, Cancer Drugs Trials Rely on Atypical Patients
    Without Older Subjects, Cancer Drugs Trials Rely on Atypical PatientsJune 3rd, 2019

Hospital Affiliations